India’s COVID-19 vaccination coverage has crossed 184 Crore landmark milestone (1,84,03,50,372) today. More than 19 lakh (19,24,770) Vaccine Doses have been administered till 7 pm today. More than 1.59 Crore (1,59,51,459) vaccine doses have been administered to 12-14 years age group so far. More than 2.30 Crore(2,30,03,879) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.
The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:
Cumulative Vaccine Dose Coverage
HCWs
1st Dose
10403626
2nd Dose
9999245
Precaution Dose
4454619
FLWs
1st Dose
18413124
2nd Dose
17508356
Precaution Dose
6856928
Age Group 12-14 years
1st Dose
15951459
Age Group 15-18 years
1st Dose
57099438
2nd Dose
37914001
Age Group 18-44 years
1st Dose
554538792
2nd Dose
465463422
Age Group 45-59 years
1st Dose
202735694
2nd Dose
185219924
Over 60 years
1st Dose
126728003
2nd Dose
115371409
Precaution Dose
11692332
Cumulative 1st dose administered
985870136
Cumulative 2nd dose administered
831476357
Precaution Dose
23003879
Total
1840350372
Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:
Date: 30th March, 2022 (439th Day)
HCWs
1st Dose
34
2nd Dose
864
Precaution Dose
9080
FLWs
1st Dose
68
2nd Dose
1901
Precaution Dose
16807
Age Group 12-14 years
1st Dose
821019
Age Group 15-18 years
1st Dose
66037
2nd Dose
169185
Age Group 18-44 years
1st Dose
61446
2nd Dose
481857
Age Group 45-59 years
1st Dose
10698
2nd Dose
110151
Over 60 years
1st Dose
7723
2nd Dose
67285
Precaution Dose
100615
Cumulative 1st dose administered
967025
Cumulative 2nd dose administered
831243
Precaution Dose
126502
Total
1924770
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.